Gadgetine

aclaris

  1. FollicleGuardian

    JAK inhibitors, the lost cure for Androgenetic Alopecia? (Incredible mistake by Aclaris)

    After looking at JAK stat inhibitors incredible success in regrowing hair in mice I started looking into what really happened to their use in Androgenetic Alopecia/male pattern baldness. Yes it’s in mice, but it performed as rapidly and effective as the dangerous hair growth promoter Smoothened Agonist (SAG). The...
  2. Noisette

    Aclaris Therapeutics Entering In Phase 2 / Taisho Pharmaceutical Ended His Phase 2a

    Just before the World congress for Hair Research and the hard work from Hellouser, some news about the pipeline. Cheers 1. Aclaris Therapeutics launchs his phase 2 for the Topical solution (Alopecia Universalis and Alopecia Totalis). - Date of first enrolment: October 23, 2017 2...
  3. Admin

    Alopecia Totalis/universalis Treatment Application Filed With Fda

    Aclaris Therapeutics has just filed an Investigational New Drug application with the FDA for a new autoimmune-inhibiting oral treatment for Alopecia Universalis and Totalis. This application paves the way for human trials in 2017. More information can be found in our Hair Loss News Center...
  4. Admin

    Aclaris Call Tomorrow - Ask Your Questions

    Tomorrow I am speaking with Aclaris and Dr. Angela Christiano regarding their JAK3 Inhibitor Research for Alopecia Areata and Androgenetic Alopecia. Please write your questions here as soon as you are able, and I will do my best to get them answered. I realize most of you care about the...
Top